• Explore /
  • Poster
  • / Feasibility study of microbial ecosystem therapeutics (MET-4) to evaluate effects of fecal microbiome in patients on immunotherapy (MET4-IO).

Feasibility study of microbial ecosystem therapeutics (MET-4) to evaluate effects of fecal microbiome in patients on immunotherapy (MET4-IO).

Abstract Poster

Authors

Tira Tan

Tira Jing Ying Tan

Princess Margaret Cancer Centre, Toronto, ON, Canada

Tira Jing Ying Tan , Marcus O. Butler , Aaron Richard Hansen , David Hogg , Adrian G. Sacher , Philippe L. Bedard , Kendra Ross , Helen Chow , Aida Al-Kindy , Sarah Boross-Harmer , Wei Xu , Bryan Coburn , Lillian L. Siu , Anna Spreafico

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2019 ASCO Annual Meeting

Session Type

Poster Session

Session Title

Developmental Immunotherapy and Tumor Immunobiology

Track

Developmental Therapeutics—Immunotherapy

Sub Track

New Targets and New Technologies (IO)

Clinical Trial Registration Number

NCT03686202

Citation

J Clin Oncol 37, 2019 (suppl; abstr TPS2664)

DOI

10.1200/JCO.2019.37.15_suppl.TPS2664

Abstract #

TPS2664

Poster Bd #

298a

Abstract Disclosures

Similar Posters

First Author: Kenneth John O'Byrne

First Author: Daniel Vilarim Araujo

First Author: Taiki Hakozaki

First Author: Marie Cumberbatch